Formulary
Nivolumab with relatlimab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Nivolumab with relatlimab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Nivolumab with relatlimab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Nivolumab with relatlimab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Melanoma**
- **Adult** (By Intravenous Infusion): Specialist drug - access specialist resources for dosing information.
Side effects
For nivolumab with relatlimab [Specialist drug] Common or very common Abdominal pain; adrenal hypofunction; alopecia; anaemia; appetite decreased; arthralgia; arthritis; chills; confusion; constipation; cough; decreased leucocytes; dehydration; diabetes mellitus; diarrhoea; dizziness; dry eye; dry mouth; dysphagia; dyspnoea; electrolyte imbalance; eosinophilia; eye disorders; eye inflammation; fatigue; fever; gastrointestinal disorders; headache; hepatitis; hyperthyroidism; hyperuricaemia; hypoalbuminaemia; hypoglycaemia; hypophysitis; hypothyroidism; increased risk of infection; influenza like illness; infusion related reaction; interstitial lung disease; muscle spasms; muscle weakness; myocarditis; nasal congestion; nausea; nerve disorders; neutropenia; oedema; pain; pancreatitis; photosensitivity reaction; proteinuria; renal impairment; skin reactions; stomatitis; taste altered; thrombocytopenia; thyroiditis; visual impairment; vomiting; weight decreased Uncommon Asthma; azoospermia; cholangitis; connective tissue disorders; haemolytic anaemia; hypogonadism; hypopituitarism; myopathy; nephritis; pericardial effusion; systemic lupus erythematosus (SLE) Frequency not known Endocrine disorders; haemophagocytic lymphohistiocytosis; hypersensitivity; lung infiltration
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Nivolumab with relatlimab [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

